Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages

Journal of Immunology

Volumn 176, Issue 1, 2006, Pages 380-389

  Sekine, Yuichi ^a   Yumioka, Taro ^a   Yamamoto, Tetsuya ^a   Muromoto, Ryuta ^a   Imoto, Seiyu ^a   Sugiyma, Kenji ^b   Oritani, Kenji ^c   Shimoda, Kazuya ^e   Minoguchi, Mayu ^f   Akira, Shizuo ^d   Yoshimura, Akihiko ^f   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; GLUTAMINE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN SH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 29644441336     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.1.380     Document Type: Article

References (47)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 7:499-511.
2. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
3. Imler, J. L., and J. A. Hoffmann. 2001. Toll receptors in innate immunity. Trends Cell. Biol. 117: 304-311.
4. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
5. O'Neill, L. A., K. A. Fitzgerald, and A. G. Bowie. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24: 286-290.
6. Burns, K., J. Clatworthy, L. Martin, F. Martinon, C. Plumpton, B. Maschera, A. Lewis, K. Ray, J. Tschopp, and F. Volpe. 2000. Tollip, a new component of the IL-1R1 pathway, links 1RAK to the IL-1 receptor. Nat. Cell. Biol. 2: 346-351.
7. Masuhara, M., K. Nagao, M. Nishikawa, M. Sasaki, A. Yoshimura, and M. Osawa. 2000. Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains. Biochem. Biophys. Res. Commun. 268: 697-703.
8. Minoguchi, M., S. Minoguchi, D. Aki, A. Joo, T. Yamamoto, T. Yumioka, T. Matsuda, and A. Yoshimura. 2003. STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif. J. Biol. Chem. 278: 11182-11189.
9. Mitchell, P. J., E. A. Sara, and M. R. Crompton. 2000. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. Oncogene 19: 4273-4282.
10. Sekine, Y., T. Yamamoto, T. Yumioka, K. Sugiyama, S. Tsuji, K. Oritani, K. Shimoda, M. Minoguchi, A. Yoshimura, and T. Matsuda. 2005. Physical and functional interactions between STAP-2/BKS and STAT5. J. Biol. Chem. 280: 8188-8196.
11. Hemmi, H., O. Takeuchi, T. Kawui, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
12. Fujita, T., G. P. Nolan, H. C. Liou, M. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kB p50 homodimers. Genes Dev. 1: 1354-1363.
13. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271: 28745-28748.
14. Sakurai, H., H. Miyoshi, W. Toriumi, and T. Sugita. 1999. Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation. J. Biol. Chem. 274: 10641-10648.
15. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7: 2135-2148.
16. Kawai, T., S. Sato, K. J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, S. Uematsu, et al. 2004. Interferon-α induction through Toll-like receptors involves a direct interaction of 1RF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068.
17. Yamamoto, T., T. Yumioka, Y. Sekine, N. Sato, M. Minoguchi, A. Yoshimura, and T. Matsuda. 2003. Regulation of FcεR1-mediated signaling by an adaptor protein STAP-2/BKS in rat basophilic leukemia RBL-2H3 cells. Biochem. Biophys. Res. Commun. 306: 767-773.
18. Tsuchiya, S., Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K. Tada. 1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42: 1530-1536.
19. Matsuda, T., T. Yamamoto, A. Muraguchi, and F. Saatcioglu. 2001. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J. Biol. Chem. 276: 42908-42914.
20. Matsumoto, M., D. Einhaus, E. S. Gold, and A. Aderem. 2004 Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J. Immunol. 172: 7377-7384.
21. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101.
22. Muromoto, R., K. Sugiyama, A. Takachi, S. Imoto, N. Sato, T. Yamamoto, K. Oritani, K. Shimoda, and T. Matsuda. 2004. Physical and functional interactions between Daxx and DNA methyltransferase 1 associated protein, DMAP1. J. Immunol. 172: 2985-2993.
23. Matsuda, T., J. Feng, B. A. Witthuhn, Y. Sekine, and J. N. Ihle. 2004. Determination of the transphosphorylation sites of Jak2 kinase. Biochem. Biophys. Res. Commun. 325: 586-594.
24. Yamamoto, T., S. Imoto, Y. Sekine, K. Sugiyama, T. Akimoto, A. Muraguchi, and T. Matsuda. 2004. Involvement of NF-κB in TGF-β-mediated suppression of 1L-4 signaling. Biochem. Biophys. Res. Commun. 313: 627-634.
25. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122.
26. da Silva Correia, J., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129-21135.
27. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105: 497-504.
28. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
29. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2: 253-258.
30. Fitzgerald, K. A., E. M. Palsson-McDermott, A. G. Bowie, C. A. Jefferies, A. S. Mansell, G. Brady, E. Brim, A. Dunne, P. Gray, M. T. Harte, et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83.
31. Horng, T., G. M. Barton, R. A. Flavell, and R. Medzhitov. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329-333.
32. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. TI-CAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4: 161-167.
33. Yamamoto, M., S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, et al. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420: 324-329.
34. Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira. 2003. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4: 1144-1150.
35. Zhang, G., and S. Ghosh. 2002. Negative regulation of Toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277: 7059-7065.
36. Kopp, E., R. Medzhitov, J. Carothers, C. Xiao, I. Douglas, C. A. Janeway, Jr., and S. Ghosh. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13: 2059-2071.
37. Moustakas, A., and C. H. Heldin. 2003. Ecsit-ement on the crossroads of Toll and BMP signal transduction. Genes Dev. 17: 2855-2859.
38. Janssens, S.. and R. Beyaert. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11: 293-302.
39. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
40. Kubo, M., T. Hanada, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4: 1169-1176.
41. Kamizono, S., T. Hanada, H. Yasukawa, S. Minoguchi, R. Kato, M. Minoguchi, K. Haltori, S. Morita, T. Kitamura, H. Kato, et al. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276: 12530-12538.
42. Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, and Z. J. Chen. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
43. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17: 677-687.
44. Karin, M. 1999. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J. Biol. Chem. 274: 27339-27342.
45. Ashikawa, K., S. Majumdar, S. Banerjee, A. C. Bharti, S. Shishodia, and B. B. Aggarwal. 2002. Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBa kinase and p65 phosphorylation. J. Immunol. 169: 6490-6497.
46. Takada, Y., A. Mukhopadhyay, G. C. Kundu, G. H. Mahabeleshwar, S. Singh, and B. B. Aggarwal. 2003. Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκB α kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 278: 24233-24241.
47. Arndt, P. G., N. Suzuki, N. J. Avdi, K. C. Malcolm, and G. S. Worthen. 2004. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-kinase and Syk-mediated pathways. J. Biol. Chem. 279: 10883-10891.